After years as a surgeon, Dr. Lishan Aklog now leads Lucid Diagnostics, a subsidiary of Pavmed, as it advances its unique technology.
More than 150 million Americans consume the product each year, and it's estimated that each consumer chews around 300 pieces ...
Cancer incidence is rising around the world, but an international study is challenging the popular narrative that young ...
Research on cancer development now firmly positions chronic inflammation as a central factor driving tumor initiation, malignant progression, and ...
University of Texas at Dallas researchers have developed biosensor technology that, when combined with artificial ...
After writer Jeri Clausing was diagnosed with breast cancer, she continued to cruise, including to Antarctica, South America, ...
Approximately 5,000 breast cancer cases among women each year could be attributed to consuming even one alcoholic drink per day.Low alcohol consumption could account for thousands of colorectal cancer ...
Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating Potential UNIONDALE, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) ...
Oct 19 (Reuters) - Swiss drugmaker Novartis (NOVN.S), opens new tab said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death in patients with prostate ...
A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...
The standing ovation for Keytruda and Padcev in metastatic bladder cancer at the 2023 European Society for Medical Oncology (ESMO) Congress still echoes, and, now, the pair from Merck & Co., Pfizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback